PCB hosts a ‘Lessons Learned’ session on investment in R & D and tax administration Blog Post

Thursday, the 22 of October, Barcelona Science Park (PCB) hosted the 8th session of ‘Lessons Learned’ series: ‘Biofiscalitat: els incentius per a la ciència‘, an initiative of CataloniaBio and Biocat to foster knowledge and networking among professionals in the field of life sciences. On this occasion, the aim of the event was to gain further insight and analyze the tools to overcome the regulations and red tape governing the taxation regimen of biotechnological and biomedical companies which hamper R & D.

 

Mind the byte concludes the biggest round of biotech crowdequity in Spain Blog Post

In just 43 days, bioinformatics company Mind the Byte, which specializes in products and services for computational drug design and is located in the Barcelona Scientific Park (PCB), has concluded an investment round totalling €234,310 through the crowdequity platform (for investment crowdfunding) Crowdcube. This figure represents not only more than double the funding target set by the company (234%), but it is also the largest round of crowdequity achieved in the biotech industry in Spain, with 115 private investors. The average investment amount was €2,037, with a maximum investment of €80,000.

 

A study applies iPSC technology to Sanfilippo syndrome research Blog Post

Sanfilippo type c syndrome is a lysosomal storage disorder caused by mutations in the HGSNAT gene that leads to progressive neurodegeneration. A study, which has just been published in the journal Stem Cell Reports, has generated patient-specific induced pluripotent stem cells (iPSC) which can contribute to know better disease’s pathological mechanisms and design new therapeutic options. A group of researchers from the Institute of Biomedicine of the University of Barcelona (IBUB) and Institute for Bioengineering of Catalonia (IBEC) at PCB has participated in the study. 

IBEC success in Human Brain Project funding call Blog Post

A study involving IBEC group leader and ICREA research professor Pau Gorostiza has been chosen for funding under a Call for Expressions of Interest (CEol) on Systems and Cognitive Neuroscience by the Human Brain Project (HBP) FET Flagship. Thanks to their success in this Call, the project partners – including IBEC – will be integrated in the broader HBP Consortium. 

 

IBEC researcher Samuel Sanchez at the ‘Innovators Under 35 Europe’ summit Blog Post

Samuel Sánchez, researcher at the Institute for Bioengineering of Catalonia (IBEC) at PCB, was among the experts invited to participate at the European summit of the winners of the MIT Technology Review’s Innovators Under 35 Europe award, which was held last week in Brussels. The research conducted by Samuel Sánchez is pioneer in the field of micro- and nanomotors, small machines such as bacteria that can target specific body cells for applications such as localized drug delivery.

 

Researchers at IBEC and UAB have found a mycobacterium that is more effective in treating superficial bladder cancer Blog Post

Researchers from Institute for Bioengineering of Catalonia (IBEC), at Barcelona Science Park (PCB), with the Mycobacteria Research Group of the Department of Genetics and Microbiology, at Universitat Autònoma de Barcelona (UAB), have found a mycobacterium that is more effective in treating superficial bladder cancer and does not cause infections, unlike those used up to now. 

 

The Ordesa Foundation collaborates with Doctors Without Borders to improve the nutrition of Congolese children Blog Post

The Ordesa Foundation will finance 34,000 units of prepared therapeutic food (RUTF) that Doctors Without Borders (MSF) will distribute to children suffering from severe acute malnutrition in the Democratic Republic of Congo. The partnership is part of the work conducted by the Ordesa Foundation to provide funding and advocacy, through direct aid, to projects aimed at children without resources. Since 2007, the Ordesa Group has R&D&i center at Barcelona Science Park (PCB), from which it is actively involved in clinical studies and national and international programs to improve people´s health and quality of life, especially in maternal and infant stage.